Oregon Health & Science University wins breakthrough stem-cell patent; ethics of cloning debated
By Nick Budnick,
The Oregonian
| 11. 02. 2011
Oregon Health & Science University's patent on a procedure to clone stem cells caps off a decade of work for Shoukhrat Mitalipov and his research team at OHSU's primate center.
The 2007 discovery, ranked by TIME Magazine one of the top two research advances of the year, now can be commercialized. Over the long-term, observers say, it could lead to the genetic engineering of human beings. But OHSU's announcement yesterday focused on short-term health gains.
“We believe our procedure has several advantages over other methods in developing new treatments for diseases such as Parkinson’s, multiple sclerosis, cardiac disease and spinal cord injuries,” said Mitalipov, an associate scientist in the Division of Reproductive Sciences. “For instance, because we transform a person’s own cells, there are no issues of rejection when the stem cells are transplanted back into a patient.”
What follows are links tracking the patent announcement, the earlier news and the resulting ethical debate over human cloning.
OHSU's Shoukhrat Mitalipov, Ph.D., discusses newly developed gene therapy method (OHSU via Youtube.com)
Scientists use monkey clones to extract stem cells (New York...
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...
